Lambev I et al. |
[Antiexudative effect of naringin in experimental pulmonary edema and peritonitis]. |
1980 |
Eksp Med Morfol |
pmid:7460808
|
Oki K et al. |
The potassium channel, Kir3.4 participates in angiotensin II-stimulated aldosterone production by a human adrenocortical cell line. |
2012 |
Endocrinology |
pmid:22798349
|
Liu M et al. |
Toxicokinetics of naringin, a putative antitussive, after 184-day repeated oral administration in rats. |
2011 |
Environ. Toxicol. Pharmacol. |
pmid:21787720
|
Nowak-Solinska E et al. |
The effect of naringin on early growth and development of the spheno-occipital synchondrosis as measured by the expression of PTHrP and Sox9--an in vitro model. |
2013 |
Eur J Orthod |
pmid:23172577
|
Sansone F et al. |
Physical characteristics and aerosol performance of naringin dry powders for pulmonary delivery prepared by spray-drying. |
2009 |
Eur J Pharm Biopharm |
pmid:18996478
|
Mielczarek C |
Acid-base properties of selected flavonoid glycosides. |
2005 |
Eur J Pharm Sci |
pmid:15911223
|
Rebello S et al. |
Intestinal OATP1A2 inhibition as a potential mechanism for the effect of grapefruit juice on aliskiren pharmacokinetics in healthy subjects. |
2012 |
Eur. J. Clin. Pharmacol. |
pmid:22124880
|
Runkel M et al. |
Metabolic and analytical interactions of grapefruit juice and 1,2-benzopyrone (coumarin) in man. |
1996 |
Eur. J. Clin. Pharmacol. |
pmid:8737764
|
Runkel M et al. |
The character of inhibition of the metabolism of 1,2-benzopyrone (coumarin) by grapefruit juice in human. |
1997 |
Eur. J. Clin. Pharmacol. |
pmid:9476043
|
Gaur V et al. |
Protective effect of naringin against ischemic reperfusion cerebral injury: possible neurobehavioral, biochemical and cellular alterations in rat brain. |
2009 |
Eur. J. Pharmacol. |
pmid:19577560
|
Wu JB et al. |
Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts. |
2008 |
Eur. J. Pharmacol. |
pmid:18495116
|
Kawaguchi K et al. |
Suppression of lipopolysaccharide-induced tumor necrosis factor-release and liver injury in mice by naringin. |
1999 |
Eur. J. Pharmacol. |
pmid:10193661
|
Nie YC et al. |
Naringin attenuates EGF-induced MUC5AC secretion in A549 cells by suppressing the cooperative activities of MAPKs-AP-1 and IKKs-IκB-NF-κB signaling pathways. |
2012 |
Eur. J. Pharmacol. |
pmid:22766066
|
Pari L and Amudha K |
Hepatoprotective role of naringin on nickel-induced toxicity in male Wistar rats. |
2011 |
Eur. J. Pharmacol. |
pmid:20950607
|
Zhang P et al. |
Effects of naringin on the proliferation and osteogenic differentiation of human bone mesenchymal stem cell. |
2009 |
Eur. J. Pharmacol. |
pmid:19326565
|
Walker AL et al. |
Transcellular movement of hydroxyurea is mediated by specific solute carrier transporters. |
2011 |
Exp. Hematol. |
pmid:21256917
|
Oliva J et al. |
Sirt1 is involved in energy metabolism: the role of chronic ethanol feeding and resveratrol. |
2008 |
Exp. Mol. Pathol. |
pmid:18793633
|
Ang ES et al. |
Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF-κB and ERK activation. |
2011 |
FEBS Lett. |
pmid:21835177
|
Iqbal MF and Zhu WY |
Bioactivation of flavonoid diglycosides by chicken cecal bacteria. |
2009 |
FEMS Microbiol. Lett. |
pmid:19473248
|
Manzanares P et al. |
Purification and characterization of an alpha-L-rhamnosidase from Aspergillus niger. |
1997 |
FEMS Microbiol. Lett. |
pmid:9435109
|